General Info
Ijeoma Agulanna@yahoo.com is a Pathologist with a background in various medical fields such as Thoracic Pathology, Anatomic and Clinical Pathology, and Polycystic Kidney Disease. They have pursued degrees in Pathology, Medical Science, Surgery, and Urology Residency, graduating from institutions like New York University and Yale School of Medicine. Ijeoma’s education includes a Doctor of Medicine (M.D.) degree and a Master’s degree. Their career spans roles like Attending Physician and Research Fellowship at esteemed medical institutions in the United States and Brazil.
Location:
Country: Nigeria
Industries:
Investment Regions: EU, MENA
Investment Stages: pre-seed, seed
angel-individual
EU, MENA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Searches for ‘Ijeoma Agulanna’ and related variants returned only an internal EasyVC page and no external sources documenting any investment activity. The EasyVC page could not be scraped. No verifiable investments or startup names and dates were found on public web results, so there is no evidence of recent or past investment activity. Therefore default to not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Ijeoma Agulanna@yahoo.com
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI